Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hepatocellular Carcinoma (HCC)
Clinical trial register · United States · industry-sponsored

Hepatocellular Carcinoma (HCC) Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9128 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 04 Nov 2026, 03:16 UTC
9128
Studies in scope
industry-sponsored, all four open statuses
4968
Recruiting now
open to new participants
2189
Lead sponsors
across recruiting studies
Top states
California 6 Florida 4 Massachusetts 4 Arizona 3 New York 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Hepatocellular Carcinoma (HCC) trials in the USA

9 of 9128 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
NCT07636785Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC), Nonsmall Cell Lung Cancer
VM Discovery, Inc.
Phase 1/2
111
Arizona, California
2026-07-16
Recruiting
A Phase 1 Study of the Safety and Tolerability of CTX-10726
NCT07419841Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC), Endometrial Cancer, Renal Cell Carcinoma (RCC)
Compass Therapeutics
Phase 1
70
Arizona, Florida, Minnesota, Nebraska, New York, Pennsylvania, South Carolina, Tennessee
2026-05-28
Recruiting
Computer Guided Microwave Liver Ablation
NCT07226869Hepatocellular Carcinoma (HCC)
NE Scientific INC
Not applicable
84
Massachusetts, New Hampshire
2026-05-08
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
California, Illinois, Michigan, New Jersey, New York, Oregon, Tennessee, Washington
2026-03-16
Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
NCT07197554Advanced Solid Tumors, Ewing Sarcoma, Hepatocellular Carcinoma (HCC), Biliary Tract Cancer (BTC)
SEED Therapeutics, Inc.
Phase 1
171
California, Massachusetts, New York, Texas
2025-12-01
Recruiting
RayzeBio, Inc.
Phase 1/2
590
Alabama, Arizona, California, Florida, Kentucky, Maryland, Minnesota, Missouri
2025-09-05
Active, closed
AstraZeneca
Phase 2
58
Colorado, Florida, Georgia, Illinois, Massachusetts, Michigan, Missouri, New Jersey
2024-02-13
Recruiting
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
NCT04634357Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Neoplasms, Metastatic Liver Cancer
Eureka Therapeutics Inc.
Phase 1/2
12
California, Massachusetts
2022-07-19
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/hepatocellular-carcinoma-hcc

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,128 studies in total at the last sync on 04 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies listing the condition Hepatocellular Carcinoma (HCC).

How many Hepatocellular Carcinoma (HCC) trials are recruiting in the US?

8 of the 9 studies on this page are recruiting new participants as of the 04 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hepatocellular Carcinoma (HCC)), 9 studies
PhaseStudiesRecruitingShare
Phase 1/24444.4%
Phase 13333.3%
Not applicable1111.1%
Phase 21011.1%

Most active sponsors

Lead sponsors with the most studies (Hepatocellular Carcinoma (HCC))
Lead sponsorStudiesRecruiting
AstraZeneca10
Bristol-Myers Squibb11
Compass Therapeutics11
Eureka Therapeutics Inc.11
NE Scientific INC11
RayzeBio, Inc.11
SEED Therapeutics, Inc.11
Shanghai Henlius Biotech11
VM Discovery, Inc.11

Top states

Top states (Hepatocellular Carcinoma (HCC)), by number of studies with a site there
StateStudies
California6
Florida4
Massachusetts4
Arizona3
New York3
Tennessee3
Illinois2
Michigan2
Minnesota2
Missouri2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.